# Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation

> **NCT07200466** · NA · RECRUITING · sponsor: **Radboud University Medical Center** · enrollment: 735 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DIAGNOSTIC_TEST:** ENDORISK personalized risk assesment for lymph node metastases in endometrial cancer.

## Key facts

- **NCT ID:** NCT07200466
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-23
- **Primary completion:** 2027-10-16
- **Final completion:** 2032-10-16
- **Target enrollment:** 735 (ESTIMATED)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07200466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07200466, "Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07200466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*